As Artisan Partners prepares to report fourth-quarter results, investors are weighing its recent track record against a backdrop of mixed signals from peers. Will this earnings release mark a turning point?
As Zurn Elkay Water Solutions prepares to report its quarterly results, investors are watching to see if the company can extend its impressive track record of exceeding revenue forecasts. We break down the key figures, peer performance, and market sentiment heading into the announcement.
In a bid to boost the global competitiveness of Indian accounting and advisory firms, the government has announced a dual-pronged reform: simplifying the 'accountant' definition under Safe Harbour Rules and merging tax computation standards with financial reporting norms.
Financial disclosures show the growing religious instruction nonprofit LifeWise Academy increased its fundraising haul last year while its net profit fell, as it expands its reach into public schools across Ohio and nationwide.
A quiet crisis is eroding the foundation of U.S. economic decision-making. As key federal data agencies face budget cuts, political pressure, and operational challenges, the resulting information gap could leave policymakers and businesses 'flying blind,' increasing the risks of policy missteps, deeper recessions, and prolonged unemployment.
While low-volatility stocks can anchor a portfolio, investors often sacrifice growth for safety. We analyze one steady performer with durable advantages and two companies where challenges may outweigh the stability premium.
As a Utah murder trial resumes, defense attorneys are pressing to remove the entire county prosecutor's office from the case, arguing the presence of a lead attorney's child at the crime scene creates an untenable conflict. Legal experts weigh the high bar for such motions.
Initial drill results from the Senneville gold-silver-copper property in Quebec's prolific Val-d'Or camp have intersected significant near-surface mineralization, with intervals up to 57.8 meters, marking a promising start to the multi-phase exploration campaign.
The Italian construction giant Webuild secures a major contract to build a critical section of the SS106 Jonica road, a project set to enhance connectivity in Calabria while creating hundreds of jobs and employing advanced construction technologies.
Defense contractor L3Harris Technologies wins a significant U.S. Navy award to develop the Red Wolf long-range precision strike vehicle for the Marine Corps, underscoring the Pentagon's focus on advanced targeting capabilities and bolstering the company's portfolio in next-generation weapons.
Crude oil benchmarks plunged over 7%, with Brent near $66 and WTI around $62, as President Trump's comments eased fears of a U.S.-Iran conflict and a sell-off in metals markets spilled over. Analysts suggest the drop reflects a rapid unwinding of risk premiums rather than a fundamental change in supply dynamics.
The Austrian government has granted a two-year renewal for the Wolfsberg lithium mining license, with a final decision on production expected by end-2026 as lithium prices rebound strongly.
A video game funded by the British government and designed for schoolchildren has drawn criticism for suggesting that questioning mass migration or researching immigration statistics could lead to referral to the UK's Prevent counter-terrorism programme.
Erasca (ERAS) gains significant analyst momentum as Mizuho initiates coverage with an 'Outperform' rating and a $16 price target, citing confidence in its 2026 proof-of-concept milestones for RAS-targeted cancer therapies.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
In a landmark deal reshaping the U.S. energy landscape, NRG Energy has completed its acquisition of LS Power's 13GW natural gas fleet and virtual power plant platform, significantly boosting its capacity and demand-response capabilities in key markets.
With its blockbuster Humira era in the rearview, AbbVie is betting big on its next-generation immunology drugs and a deep pipeline to drive growth and maintain its crown among Dividend Kings.
Alibaba Group has pledged 3 billion yuan ($431 million) to promote its Qwen AI app during the upcoming Lunar New Year holiday, significantly outpacing similar campaigns by rivals Tencent and Baidu and marking a major escalation in China's competitive AI landscape.
The Hong Kong Monetary Authority (HKMA) is poised to grant its inaugural stablecoin issuer licenses in March, with approvals expected for only a select few firms. The move transitions the city's digital asset framework from sandbox testing to a formally regulated market, focusing on stringent risk controls and credible use cases.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
